Equity Overview
Price & Market Data
Price: $1.20
Daily Change: $0.00 / 0.00%
Daily Range: $1.14 - $1.21
Market Cap: $30,363,670
Daily Volume: 40,682
Performance Metrics
1 Week: 26.50%
1 Month: -11.76%
3 Months: 24.87%
6 Months: 72.85%
1 Year: -84.47%
YTD: 9.09%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.